n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with Cardiac Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pollack, JR; Sugimoto, JT; Witt, RC | 1 |
| Arthur, GD; Belcastro, AN | 1 |
2 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Differential effects of calpain inhibitors on hypertrophy of cardiomyocytes.
Topics: Acrylates; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Calpain; Cardiomegaly; Cells, Cultured; Cysteine Proteinase Inhibitors; Glycoproteins; Heart Ventricles; Leucine; Myocytes, Cardiac; Phenylephrine; Rats; Time Factors; Ventricular Function, Left | 2003 |
A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calpain; Cardiomegaly; Cyclic AMP; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Activation; Isoproterenol; Leucine; Male; Rats; Rats, Wistar; RNA; Ventricular Function, Left | 1997 |